PIL - Diamorphine Hydrochloride BP 100 mg, 500mg Lyophilisate for Solution for Injection: Change history
View Patient Information Leaflet (PIL - Diamorphine Hydrochloride BP 100 mg, 500mg Lyophilisate for Solution for Injection)
Last updated on this site: 12 Nov 2025
Update to SPC and PIL for causal relationship between diamorphine and opioid use disorders, sleep-related breathing disorders, and interactions with gabapentinoids and anticholinergics in line with PSUSA/00001028/202411 for products with pain indication.
Variation approved 04/11/2025
SmPC sections updated 4.4, 4.5, 4.8 and 10
View Patient Information Leaflet (PIL - Diamorphine Hydrochloride BP 100 mg, 500mg Lyophilisate for Solution for Injection)
Last updated on this site: 12 Nov 2025
Update to SPC and PIL for causal relationship between diamorphine and opioid use disorders, sleep-related breathing disorders, and interactions with gabapentinoids and anticholinergics in line with PSUSA/00001028/202411 for products with pain indication.
Variation approved 04/11/2025
SmPC sections updated 4.4, 4.5, 4.8 and 10
-
Changes: (Updated: 2025-11-12T15:40:30.000000Z)
Update to SPC and PIL for causal relationship between diamorphine and opioid use disorders, sleep-related breathing disorders, and interactions with gabapentinoids and anticholinergics in line with PSUSA/00001028/202411 for products with pain indication.
Variation approved 04/11/2025
SmPC sections updated 4.4, 4.5, 4.8 and 10
-
Changes: (Updated: 2023-07-21T07:32:17.000000Z)
Website administration update
-
Changes: (Updated: 2022-09-20T10:43:54.000000Z)
Initial upload
-
Changes: (Updated: 2022-09-20T10:39:17.000000Z)
Initial upload